Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Allogene Therapeutics, Inc. (ALLO)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
18 Dec 2023
MESSEMER DEBORAH M.
Director
Allogene Therapeutics, Inc.
(ALLO)
62,456
-22%
18,640
$2.70
$50,316.82
SELL
7 Aug 2023
Mayo Stephen
Director
Allogene Therapeutics, Inc.
(ALLO)
25,328
-28%
10,000
$4.29
$42,855.00
SELL
13 Feb 2023
Bhavnagri Veer
General Counsel, Officer
Allogene Therapeutics, Inc.
(ALLO)
577,677
-0%
3,000
$6.85
$20,550.00
SELL
17 Jan 2023
Bhavnagri Veer
General Counsel, Officer
Allogene Therapeutics, Inc.
(ALLO)
580,677
-0%
3,000
$7.04
$21,120.00
SELL
15 Dec 2022
Bhavnagri Veer
General Counsel, Officer
Allogene Therapeutics, Inc.
(ALLO)
583,677
-0%
5,602
$7.53
$42,186.42
SELL
11 Aug 2022
WITTE OWEN N.
Director
Allogene Therapeutics, Inc.
(ALLO)
218,271
-6%
15,000
$16.75
$251,250.00
SELL
11 Aug 2022
WITTE OWEN N.
Director
Allogene Therapeutics, Inc.
(ALLO)
218,271
-6%
15,000
$16.75
$251,250.00
SELL
5 Jul 2022
Amado Rafael
EVP of R&D and CMO, Officer
Allogene Therapeutics, Inc.
(ALLO)
542,257
-0%
2,000
$11.44
$22,880.00
SELL
22 Jun 2022
WITTE OWEN N.
Director
Allogene Therapeutics, Inc.
(ALLO)
233,271
-4%
10,000
$11.76
$117,600.00
SELL
21 Jun 2022
Amado Rafael
EVP of R&D and CMO, Officer
Allogene Therapeutics, Inc.
(ALLO)
544,257
-0%
2,000
$11.18
$22,360.00
SELL
19 May 2022
Amado Rafael
EVP of R&D and CMO, Officer
Allogene Therapeutics, Inc.
(ALLO)
546,257
-2%
11,500
$7.40
$85,091.95
SELL
15 Mar 2022
Chang David D
President and CEO, Director, Officer
Allogene Therapeutics, Inc.
(ALLO)
2,289,652
-1%
23,648
$7.65
$180,878.81
SELL
15 Mar 2022
SCHMIDT ERIC THOMAS
Chief Financial Officer, Officer
Allogene Therapeutics, Inc.
(ALLO)
100,546
-10%
11,469
$7.63
$87,550.91
SELL
15 Mar 2022
Amado Rafael
EVP of R&D and CMO, Officer
Allogene Therapeutics, Inc.
(ALLO)
320,119
-1%
5,169
$7.71
$39,847.82
SELL
15 Mar 2022
Bhavnagri Veer
General Counsel, Officer
Allogene Therapeutics, Inc.
(ALLO)
413,841
-2%
8,849
$7.68
$67,962.09
SELL
15 Mar 2022
MOORE ALISON
Chief Technical Officer, Officer
Allogene Therapeutics, Inc.
(ALLO)
120,430
-6%
8,698
$7.63
$66,388.35
BUY
12 Jan 2022
Belldegrun Arie
Director
Allogene Therapeutics, Inc.
(ALLO)
195,039
+387%
155,039
$12.60
$1,953,491.50
BUY
12 Jan 2022
Kazam Joshua A
Director
Allogene Therapeutics, Inc.
(ALLO)
258,885
+6%
15,000
$12.60
$189,000.00
SELL
1 Oct 2021
Amado Rafael
EVP of R&D and CMO, Officer
Allogene Therapeutics, Inc.
(ALLO)
323,928
-3%
11,507
$24.35
$280,185.10
SELL
15 Sep 2021
Bhavnagri Veer
General Counsel, Officer
Allogene Therapeutics, Inc.
(ALLO)
421,669
-1%
5,000
$24.77
$123,844.50
SELL
9 Sep 2021
WITTE OWEN N.
Director
Allogene Therapeutics, Inc.
(ALLO)
221,182
-2%
5,000
$25.54
$127,700.01
SELL
20 Aug 2021
WITTE OWEN N.
Director
Allogene Therapeutics, Inc.
(ALLO)
231,182
-4%
10,000
$23.47
$234,700.00
SELL
16 Aug 2021
Bhavnagri Veer
General Counsel, Officer
Allogene Therapeutics, Inc.
(ALLO)
421,353
-1%
5,000
$21.00
$104,994.00
SELL
15 Jul 2021
Bhavnagri Veer
General Counsel, Officer
Allogene Therapeutics, Inc.
(ALLO)
421,353
-1%
5,000
$21.55
$107,753.00
SELL
15 Jun 2021
Bhavnagri Veer
General Counsel, Officer
Allogene Therapeutics, Inc.
(ALLO)
421,353
-1%
5,000
$25.32
$126,600.00
SELL
9 Jun 2021
WITTE OWEN N.
Director
Allogene Therapeutics, Inc.
(ALLO)
236,182
-4%
9,969
$25.05
$249,723.44
SELL
18 May 2021
Bhavnagri Veer
General Counsel, Officer
Allogene Therapeutics, Inc.
(ALLO)
421,353
-1%
5,000
$30.00
$150,000.00
SELL
17 May 2021
Bhavnagri Veer
General Counsel, Officer
Allogene Therapeutics, Inc.
(ALLO)
421,353
-1%
5,000
$28.30
$141,475.50
SELL
15 Apr 2021
Bhavnagri Veer
General Counsel, Officer
Allogene Therapeutics, Inc.
(ALLO)
421,959
-2%
10,000
$32.05
$320,517.38
SELL
15 Mar 2021
Chang David D
President and CEO, Director, Officer
Allogene Therapeutics, Inc.
(ALLO)
2,204,417
-0%
20,513
$38.57
$791,270.50
SELL
15 Mar 2021
SCHMIDT ERIC THOMAS
Chief Financial Officer, Officer
Allogene Therapeutics, Inc.
(ALLO)
71,231
-10%
8,053
$38.23
$307,888.75
SELL
15 Mar 2021
Amado Rafael
EVP of R&D and CMO, Officer
Allogene Therapeutics, Inc.
(ALLO)
110,035
-2%
2,798
$38.05
$106,470.61
SELL
15 Mar 2021
MOORE ALISON
Chief Technical Officer, Officer
Allogene Therapeutics, Inc.
(ALLO)
102,574
-5%
6,164
$38.14
$235,089.40
SELL
15 Mar 2021
Bhavnagri Veer
General Counsel, Officer
Allogene Therapeutics, Inc.
(ALLO)
409,151
-3%
16,623
$37.95
$630,798.40
SELL
14 Jan 2021
SCHMIDT ERIC THOMAS
Chief Financial Officer, Officer
Allogene Therapeutics, Inc.
(ALLO)
1,164,048
-2%
30,000
$31.52
$945,469.10
SELL
16 Nov 2020
SCHMIDT ERIC THOMAS
Chief Financial Officer, Officer
Allogene Therapeutics, Inc.
(ALLO)
1,192,961
-1%
15,000
$32.88
$493,146.38
SELL
15 Oct 2020
SCHMIDT ERIC THOMAS
Chief Financial Officer, Officer
Allogene Therapeutics, Inc.
(ALLO)
1,207,491
-1%
15,000
$40.49
$607,392.40
SELL
12 Oct 2020
MOORE ALISON
Chief Technical Officer, Officer
Allogene Therapeutics, Inc.
(ALLO)
108,370
-24%
35,264
$42.00
$1,481,088.00
SELL
8 Oct 2020
MOORE ALISON
Chief Technical Officer, Officer
Allogene Therapeutics, Inc.
(ALLO)
108,370
-29%
44,574
$41.00
$1,827,534.00
SELL
7 Oct 2020
Amado Rafael
EVP of R&D and CMO, Officer
Allogene Therapeutics, Inc.
(ALLO)
111,677
-12%
16,538
$39.40
$651,514.50
SELL
6 Oct 2020
MOORE ALISON
Chief Technical Officer, Officer
Allogene Therapeutics, Inc.
(ALLO)
117,680
-27%
44,574
$40.00
$1,782,960.00
SELL
6 Oct 2020
Bhavnagri Veer
General Counsel, Officer
Allogene Therapeutics, Inc.
(ALLO)
353,902
-2%
10,000
$40.00
$400,000.00
SELL
1 Oct 2020
Bhavnagri Veer
General Counsel, Officer
Allogene Therapeutics, Inc.
(ALLO)
362,687
-6%
25,000
$36.52
$912,912.75
SELL
1 Oct 2020
Amado Rafael
EVP of R&D and CMO, Officer
Allogene Therapeutics, Inc.
(ALLO)
128,215
-7%
9,752
$36.37
$354,661.72
SELL
21 Sep 2020
SCHMIDT ERIC THOMAS
Chief Financial Officer, Officer
Allogene Therapeutics, Inc.
(ALLO)
1,217,706
-1%
15,000
$35.30
$529,544.80
SELL
1 Sep 2020
Bhavnagri Veer
General Counsel, Officer
Allogene Therapeutics, Inc.
(ALLO)
354,302
-6%
25,000
$35.36
$883,965.94
SELL
6 Aug 2020
TPG Group Holdings (SBS) Advisors, Inc.
10% Owner
Allogene Therapeutics, Inc.
(ALLO)
18,723,992
-0%
37,445
$37.47
$1,403,030.50
SELL
3 Aug 2020
Bhavnagri Veer
General Counsel, Officer
Allogene Therapeutics, Inc.
(ALLO)
370,352
-7%
31,553
$36.89
$1,164,120.90
SELL
26 Jun 2020
TPG Group Holdings (SBS) Advisors, Inc.
10% Owner
Allogene Therapeutics, Inc.
(ALLO)
19,716,306
-0%
85,151
$42.53
$3,621,601.00
SELL
23 Jun 2020
TPG Group Holdings (SBS) Advisors, Inc.
10% Owner
Allogene Therapeutics, Inc.
(ALLO)
19,801,456
-1%
219,853
$44.04
$9,682,651.00
SELL
18 Jun 2020
TPG Group Holdings (SBS) Advisors, Inc.
10% Owner
Allogene Therapeutics, Inc.
(ALLO)
20,064,164
-1%
314,792
$42.50
$13,379,624.00
SELL
15 Jun 2020
TPG Group Holdings (SBS) Advisors, Inc.
10% Owner
Allogene Therapeutics, Inc.
(ALLO)
20,336,102
-1%
390,984
$42.18
$16,491,046.00
BUY
4 Jun 2020
Belldegrun Arie
Director
Allogene Therapeutics, Inc.
(ALLO)
40,000
+137%
146,382
$47.00
$6,879,954.00
SELL
3 Jun 2020
TPG Group Holdings (SBS) Advisors, Inc.
10% Owner
Allogene Therapeutics, Inc.
(ALLO)
20,727,086
-2%
489,220
$47.40
$23,188,152.00
SELL
16 Mar 2020
Chang David D
President and CEO, Director, Officer
Allogene Therapeutics, Inc.
(ALLO)
2,215,426
-0%
20,335
$19.31
$392,615.22
SELL
16 Mar 2020
SCHMIDT ERIC THOMAS
Chief Financial Officer, Officer
Allogene Therapeutics, Inc.
(ALLO)
47,257
-10%
5,450
$19.73
$107,507.85
SELL
16 Mar 2020
MOORE ALISON
Chief Technical Officer, Officer
Allogene Therapeutics, Inc.
(ALLO)
63,021
-5%
3,750
$19.19
$71,980.13
SELL
18 Feb 2020
Dianne Feinstein
Congressman (Senate)
Allogene Therapeutics, Inc.
(ALLO)
N/A
N/A
N/A
$1,000,001 - $5,000,000
SELL
31 Jan 2020
Dianne Feinstein
Congressman (Senate)
Allogene Therapeutics, Inc.
(ALLO)
N/A
N/A
N/A
$500,001 - $1,000,001
SELL
16 Sep 2019
MOORE ALISON
Chief Technical Officer, Officer
Allogene Therapeutics, Inc.
(ALLO)
66,067
-42%
48,827
$32.11
$1,567,666.20
SELL
26 Jul 2019
MOORE ALISON
Chief Technical Officer, Officer
Allogene Therapeutics, Inc.
(ALLO)
65,373
-42%
48,827
$29.44
$1,437,602.80
SELL
3 Jun 2019
MOORE ALISON
Chief Technical Officer, Officer
Allogene Therapeutics, Inc.
(ALLO)
39,180
-55%
48,828
$26.76
$1,306,774.40
SELL
14 May 2019
TPG Group Holdings (SBS) Advisors, Inc.
10% Owner
Allogene Therapeutics, Inc.
(ALLO)
21,216,306
-8%
1,918,755
$29.38
$56,373,020.00
BUY
13 May 2019
Dianne Feinstein
Congressman (Senate)
Allogene Therapeutics, Inc.
(ALLO)
N/A
N/A
N/A
$500,001 - $1,000,001
BUY
15 Oct 2018
PFIZER INC
10% Owner
Allogene Therapeutics, Inc.
(ALLO)
22,032,040
+0%
55,556
$18.00
$1,000,008.00
BUY
15 Oct 2018
Chang David D
President and CEO, Director, Officer
Allogene Therapeutics, Inc.
(ALLO)
1,995,625
+2%
40,000
$18.00
$720,000.00
BUY
15 Oct 2018
Belldegrun Arie
Director, 10% Owner
Allogene Therapeutics, Inc.
(ALLO)
35,000
+100%
35,000
$18.00
$630,000.00
BUY
15 Oct 2018
WITTE OWEN N.
Director
Allogene Therapeutics, Inc.
(ALLO)
198,750
+8%
15,000
$18.00
$270,000.00
BUY
15 Oct 2018
Humer Franz B
Director
Allogene Therapeutics, Inc.
(ALLO)
30,000
+100%
30,000
$18.00
$540,000.00
BUY
15 Oct 2018
TPG Group Holdings (SBS) Advisors, Inc.
10% Owner
Allogene Therapeutics, Inc.
(ALLO)
23,135,060
+3%
675,000
$18.00
$12,150,000.00
Home